BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5520275)

  • 1. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
    Marova EI; Lemesheva SN
    Probl Endokrinol (Mosk); 1970; 16(5):7-10. PubMed ID: 5520275
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1843-51. PubMed ID: 4236505
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of amino-glutethimide in the ectopic ACTH syndrome.
    Gorden P; Becker CE; Levey GS; Roth J
    J Clin Endocrinol Metab; 1968 Jun; 28(6):921-3. PubMed ID: 4172920
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of Cushing's disease treated by aminoglutethimide].
    Thevenet M; Lumbroso P; Netter A
    Ann Endocrinol (Paris); 1968; 29(3):346-50. PubMed ID: 4326387
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR; Camacho A; Patterson P
    Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatty acid composition of the sterol ester fraction of human adrenal cortex in Cushingś syndrome and after treatment with aminoglutethimide.
    Raggatt PR; Engel LL; Symington T
    Lipids; 1972 Jul; 7(7):474-82. PubMed ID: 5049143
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K; Küchel O; Gregorvá I; Stárka L
    J Clin Endocrinol Metab; 1969 Feb; 29(2):297-9. PubMed ID: 4236926
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 9. Amino-glutethimide (elipten) in adenocortical carcinoma.
    Miranda-Zetterstrand N; Díaz-Bonet L; Pagán-Sáez H; Rosaly de Jirau W
    Bol Asoc Med P R; 1968 Dec; 60(12):611-8. PubMed ID: 5253414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitions of steroid biosynthesis in the adrenal gland by aminogluthetimide (Elipten CIBA) and its practical significance].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Vnitr Lek; 1969 May; 15(5):417-25. PubMed ID: 5792533
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M; Maisey MN
    Acta Endocrinol (Copenh); 1970 Aug; 64(4):676-86. PubMed ID: 4318105
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.
    Faglia G; Gattinoni L; Travaglini P; Neri V; Acerbi L; Ambrosi B
    Metabolism; 1971 Mar; 20(3):266-72. PubMed ID: 5546922
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reduced excretion of total gonadotropins during use of Elipten in breast neoplasms].
    Eliubaeva GO; Sanchakova AV; Vishnevskiĭ AS; Dil'man VM
    Vopr Onkol; 1972; 18(3):92-3. PubMed ID: 5017847
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W
    Q J Med; 1971 Oct; 40(160):568-9. PubMed ID: 5157412
    [No Abstract]   [Full Text] [Related]  

  • 15. [A comparative evaluation of the functional state of the adrenal cortex in puberty-juvenile dyspituitarism and Itsenko-Cushing disease (second report)].
    Egart FM; Lemesheva SN; Goncharova VN
    Probl Endokrinol (Mosk); 1973; 19(4):37-40. PubMed ID: 4788098
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.
    Barnett IG; Nabarro JD; LeQuesne LP
    Proc R Soc Med; 1970 Apr; 63(4):338-9. PubMed ID: 5441960
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE; Conn JW
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of aminoglutethimide on cortisol secretion in Cushing's disease].
    Boyer J; Valette A; Latrabe J; Codaccioni JL
    Ann Endocrinol (Paris); 1973; 34(5):519-26. PubMed ID: 4368116
    [No Abstract]   [Full Text] [Related]  

  • 19. Aminoglutethimide: a "side-effect" turned to therapeutic advantage.
    Hughss SW; Burley DM
    Postgrad Med J; 1970 Jul; 46(537):409-16. PubMed ID: 4920933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of metopyrone on the levels of ACTH and 11-HCS in the plasma and the excretion of individual 17-HCS and 17-KS in Itsenko-Cushing disease].
    Marova EI; Lemesheva SN; Makarovskaia EE; Fedoseeva GI; Starkova NT
    Probl Endokrinol (Mosk); 1972; 18(3):7-12. PubMed ID: 4337678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.